Advertisement

Reactions Weekly

, Volume 1761, Issue 1, pp 24–24 | Cite as

Alemtuzumab

Immune thrombocytopenia, neutropenia and hyperthyroidism: 3 case reports
Case report
  • 11 Downloads

Reference

  1. Reddel SW, et al. Successful implementation of an automated electronic support system for patient safety monitoring: The alemtuzumab in multiple sclerosis safety systems (AMS3) study. Multiple Sclerosis Journal 25: 1124-1131, No. 8, 18 Jun 2018. Available from: URL: http://doi.org/10.1177/1352458518783673 -Australia

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations